 visitante ::
identificación
|
|||||||||||||||
|
Buscar | Enviar | Ayuda | Servicio de Bibliotecas | Sobre el DDD | Català English Español | |||||||||
| Página principal > Artículos > Artículos publicados > Recommendations for living donor kidney transplantation Recomendaciones para el trasplante renal de donante vivo |
(Hospital del Mar (Barcelona, Catalunya)) (Institut d'Investigació Biomèdica Sant Pau) (Hospital Clínic i Provincial de Barcelona. Servei de Nefrologia i Trasplantament Renal) (Institut d'Investigació Biomèdica Sant Pau) (Hospital Clínic i Provincial de Barcelona. Unitat d'Afèresi i Teràpia Cel·lular. Servei d'Hemoteràpia i Hemostàsia) (Hospital Clínic i Provincial de Barcelona. Servei de Nefrologia i Trasplantament Renal) (Institut d'Investigació Biomèdica Sant Pau) (Hospital Clínic i Provincial de Barcelona. Servei d'Hemoteràpia i Hemostàsia.) (Hospital Clínic i Provincial de Barcelona. Servei de Nefrologia i Trasplantament Renal) (Hospital Clínic i Provincial de Barcelona. Servei d'Immunologia) (Institut d'Investigació Biomèdica Sant Pau) (Hospital del Mar (Barcelona, Catalunya))
| Fecha: | 2022 |
| Resumen: | This Guide for Living Donor Kidney Transplantation (LDKT) has been prepared with the sponsorship of the Spanish Society of Nephrology (SEN), the Spanish Transplant Society (SET), and the Spanish National Transplant Organization (ONT). It updates evidence to offer the best chronic renal failure treatment when a potential living donor is available. The core aim of this Guide is to supply clinicians who evaluate living donors and transplant recipients with the best decision-making tools, to optimise their outcomes. Moreover, the role of living donors in the current KT context should recover the level of importance it had until recently. To this end the new forms of incompatible HLA and/or ABO donation, as well as the paired donation which is possible in several hospitals with experience in LDKT, offer additional ways to treat renal patients with an incompatible donor. Good results in terms of patient and graft survival have expanded the range of circumstances under which living renal donors are accepted. Older donors are now accepted, as are others with factors that affect the decision, such as a borderline clinical history or alterations, which when evaluated may lead to an additional number of transplantations. This Guide does not forget that LDKT may lead to risk for the donor. Pre-donation evaluation has to centre on the problems which may arise over the short or long-term, and these have to be described to the potential donor so that they are able take them into account. Experience over recent years has led to progress in risk analysis, to protect donors' health. This aspect always has to be taken into account by LDKT programmes when evaluating potential donors. Finally, this Guide has been designed to aid decision-making, with recommendations and suggestions when uncertainties arise in pre-donation studies. Its overarching aim is to ensure that informed consent is based on high quality studies and information supplied to donors and recipients, offering the strongest possible guarantees. |
| Ayudas: | Instituto de Salud Carlos III RD16/0009/0013 Instituto de Salud Carlos III INT21/00003 Ministerio de Economía y Competitividad ICI14/00016 Ministerio de Economía y Competitividad PI17/02043 |
| Nota: | Altres ajuts: European Regional Development (Fund-ERDF). |
| Derechos: | Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.  |
| Lengua: | Castellà |
| Documento: | Article ; recerca ; Versió publicada |
| Publicado en: | Nefrología (Badalona. English), Vol. 42 (diciembre 2022) , p. 5-132, ISSN 2013-2514 |
